🔎 Trials Near Me

Gara Jalqabaatti › Kansa Mataa fi Morma › North Carolina

Qorannoo klinikaalii Kansa Mataa fi Morma North Carolina keessatti

Qorannoo 14 Kansa Mataa fi Morma f North Carolina keessatti hirmaatuu jiru.

Magaalota North Carolina keessatti

Takkalaa qorannoo (Ingiliffa)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Duke University, Durham
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

  • Site#0118, Durham
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06788990

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Novant Health Cancer Institute - Kernersville, Kernersville
  • Novant Health Cancer Institute - Mount Airy, Mount Airy
  • Novant Health Forsyth Medical Center, Winston-Salem
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07059884

DESTINY-PANTUMOUR04

  • Research Site, Durham
  • Research Site, Wilson
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

  • Levine Cancer Institute, Charlotte
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06607406

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06096038

Effects of Infusion Timing on Treatment Response in Solid Tumors

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07630168

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Carolina BioOncology Institute, Huntersville
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT06993844

Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma

  • University of North Carolina at Chapel Hill, Chapel Hill
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Gur-2026 · NCT04099290

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Gur-2026 · NCT07278557

X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma

  • Levine Cancer Institute, Charlotte
  • Duke University, Durham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ama-2026 · NCT04389281

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

  • Duke University Medical Center, Durham
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Mud-2025 · NCT05793151

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chapel Hill
  • Massive Bio SYNERGY-AI site, Winston-Salem
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

  • Levine Cancer Institute, Charlotte
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Hag-2025 · NCT04429542

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.